+8.2%
GSK vs ONTO
+53.2%
-45.0%
-22.4%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | ONTO | Excess | Alpha |
|---|---|---|---|---|
| 1D | -1.2% | +8.9% | -10.1% | -0.8% |
| 7D | -1.1% | +16.4% | -17.4% | -0.2% |
| 30D | +7.8% | -21.4% | +29.3% | +6.8% |
| 3M | +0.3% | -32.7% | +33.1% | -0.9% |
| 6M | +3.4% | -25.2% | +28.6% | +1.9% |
| YTD | +5.9% | +36.2% | -30.3% | +1.1% |
| 1Y | +8.2% | +61.2% | -52.9% | +1.4% |
| All | +8.2% | +53.2% | -45.0% | +1.4% |
Cumulative growth
Daily Returns
Daily percentage return beside ONTO.
Daily Out/Under-Performance
Portfolio return minus ONTO return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × ONTO return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded ONTO wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling